Web NewDrugInformation.com

M.V.I. Adult Drug - M.V.I. Adult The trade name of the product as shown on the labeling. Dosage - INJECTABLE; IV (INFUSION) The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Ascorbic Acid; Biotin; Cyanocobalamin; Dexpanthenol; Ergocalciferol; Folic Acid; Niacinamide; Pyridoxine Hydrochloride; Riboflavin Phosphate Sodium; Thiamine Hydrochloride; Vitamin A; Vitamin E; Vitamin K Multiple ingredients are in alphabetical order. Strength - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL The potency of the active ingredient(s), Ascorbic Acid; Biotin; Cyanocobalamin; Dexpanthenol; Ergocalciferol; Folic Acid; Niacinamide; Pyridoxine Hydrochloride; Riboflavin Phosphate Sodium; Thiamine Hydrochloride; Vitamin A; Vitamin E; Vitamin K. May repeat for multiple part products. Applicant - MAYNE PHARMA USA The firm name holding legal responsibility for M.V.I. Adult. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 021625 The FDA assigned number to M.V.I. Adult. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify M.V.I. Adult. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Jan 30, 2004 The date M.V.I. Adult was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - Yes The pioneer or innovator of M.V.I. Adult. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs M.V.I. Adult is in. Format is RX, OTC, DISCN. Applicant Full Name - Mayne Pharma Usa Inc The full name of the firm holding legal responsibility for the new application of M.V.I. Adult. M.V.I. Adult Mvc Plus 10mg/ml;0.006mg/ml;0.5ugm/ml;1.5mg/ml;20 Iu/ml;0.04mg/ml;4mg/ml;0.4mg/ml;0.36mg/ml;0.3mg/ml;330 Units/ml;1 Iu/ml Injectable; Injection M.V.I. Adult 200mg/vial;0.06mg/vial;0.005mg/vial;15mg/vial;0.005mg/vial;0.6mg/vial;40mg/vial;6mg/vial;3.6mg/vial;6mg/vial;1mg/vial;10mg/vial;0.15mg/vial Injectable; Iv (infusion) Septocaine 4%;eq 0.01mg Base/ml Injectable; Injection Infuvite Pediatric 80mg/vial;0.02mg/vial;400 Iu/vial;0.001mg/vial;5mg/vial;0.14mg/vial;17mg/vial;1mg/vial;1.4mg/vial;1.2mg/vial;7 Iu/vial;2,300 Iu/vial;0.2mg/vial Injectable; Iv (infusion) Infuvite Pediatric (pharmacy Bulk Package) 80mg/vial;0.02mg/vial;400 Iu/vial;0.001mg/vial;5mg/vial;0.14mg/vial;17mg/vial;1mg/vial;1.4mg/vial;1.2mg/vial;7 Iu/vial;2,300 Iu/vial;0.2mg/vial Injectable; Iv (infusion) M.V.I. Pediatric 80mg/vial;0.02mg/vial;0.001mg/vial;5mg/vial;0.01mg/vial;0.14mg/vial;17mg/vial;0.2mg/vial;1mg/vial;1.4mg/vial;eq 1.2mg Base/vial;0.7mg/vial;7mg/vial For Solution; Iv (infusion) Berocca Pn 50mg/ml;0.03mg/ml;0.0025mg/ml;7.5mg/ml;100 Iu/ml;0.2mg/ml;20mg/ml;2mg/ml;1.8mg/ml;1.5mg/ml;1,650 Iu/ml;5 Iu/ml Injectable; Injection M.V.C. 9+3 10mg/ml;0.006mg/ml;0.5ugm/ml;1.5mg/ml;20 Iu/ml;0.04mg/ml;4mg/ml;0.4mg/ml;0.36mg/ml;0.3mg/ml;330 Units/ml;1 Iu/ml Injectable; Injection M.V.I.-12 10mg/ml;0.006mg/ml;0.5ugm/ml;1.5mg/ml;20 Iu/ml;0.04mg/ml;4mg/ml;0.4mg/ml;0.36mg/ml;0.3mg/ml;330 Units/ml;1 Iu/ml Injectable; Injection M.V.I.-12 (without Vitamin K) 20mg/ml;0.006mg/ml;0.05ugm/ml;1.5mg/ml;0.0005mg/ml;0.06mg/ml;4mg/ml;0.6mg/ml;0.36mg/ml;0.6mg/ml;0.1mg/ml;1mg/ml Injectable; Injection NewDrugInformation